Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease. (Q48594192)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 1997

Language	Label	Description	Also known as
English	Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease.	scientific article published in September 1997

Statements

scholarly article

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease. (English)

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Alzheimer's disease

0 references

author name string

Aizawa Y

1

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Fukatsu R

2

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Takamaru Y

3

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Tsuzuki K

4

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Chiba H

5

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Kobayashi K

6

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Fujii N

7

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Takahata N

8

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

language of work or name

0 references

publication date

1 September 1997

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

768

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

1-2

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

208-214

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

SP-40,40 is a constituent of Alzheimer's amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Expression of apolipoprotein E during nerve degeneration and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

The site of the earliest lesions of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Alzheimer's beta-amyloid peptide is conformationally modified by apolipoprotein E in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Is Alzheimer's disease an apolipoprotein E amyloidosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900640-9

7 January 2021

Identifiers

10.1016/S0006-8993(97)00640-9

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9369317

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48594192&oldid=2164444381"